Hepatitis B Vaccine Market Analysis
The Hepatitis B Vaccine Market, valued at USD 8.26 billion in 2023, is projected to grow to USD 11.84 billion by 2031. This growth reflects an emerging compound annual growth rate (CAGR) of 4.6% over the forecast period from 2024 to 2031.
Hepatitis B is a serious liver infection caused by the hepatitis B virus (HBV), and vaccination remains the most effective...
English
Arabic
Français
Español
Português
Deutsch
Dutch
Italiano
Russian
Romaian